Vivimed Labs Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India, Mexico, Spain, Hungary, and internationally. It operates in two segments, Specialty Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers a range of hair dye intermediates for use in permanent, semi-permanent, and temporary hair colorant systems; oxidation dye couplers and bases to formulate various permanent and demi-permanent shades; direct dyes for semi-permanent formulations; and basic dyes for temporary, semi-permanent, and color-refresher shampoos and conditioners under the Jarocol name. In addition, the company manufactures and markets photochromic dyes under the Reversacol name; and anti-microbial actives for use in a range of applications, including plastics additives and anti-bacterial handwashes. Further, it offers photographic chemicals, such as black and white developers, and antifog additives for use in medical and industrial X-ray imaging, consumer photography, and litho-plate production for the graphic arts industry. Additionally, the company manufactures Favulous for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company was incorporated in 1988 and is based in Hyderabad, India.
|Industry / Sector||Drug Manufacturers—Specialty & Generic / Healthcare|
|Mailing address||North End Road No.2 Banjara Hills Hyderabad 500034 India|
|Phone / Fax||91 40 6608 6608 / 91 40 6608 6699|
Vivimed Labs Limited paid ₹0.00 dividend and the ex-dividend date was 19 Sept 2018.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.VIVIMEDLAB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
VIVIMEDLAB's forward dividend amount is ₹ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Jul 2022, following are the company executives and directors listed on Vivimed Labs Limited.
|Mr. Santosh Varalwar||MD & Exec. Director||59||6M|
|Mr. Yugandhar Kopparthi||Compliance Officer & Company Sec.||2.82M|
|Dr. Manohar Rao Varalwar||Whole Time Director||85||6M|
|Mr. Sandeep Varalwar||Exec. Director||53||6M|
|Mr. Ramakanta Tripathy||Chief Financial Officer|
|Mr. Mark I. Robbins||Chief Exec. of Uquifa - Vivimed's API Division|
|Snehashree Joshi||Assistant Company Sec.|
|Mr. Amarjit Singh Bhatia B.Com. CA MBA '(Mktg.) AISSSE||Advisor of Vivimed Group||57|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Vivimed Labs Limited is and its enterprise value is .
The VIVIMEDLAB's stocks Beta value is 1.11 making it 11% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Vivimed Labs Limited (NSE:VIVIMEDLAB) Frequently Asked Questions
1. What is Vivimed Labs Limited's Stock Symbol?
Vivimed Labs Limited trades on NSE under the ticker symbol "VIVIMEDLAB".
2. What is Vivimed Labs Limited's stock price today?
One share of VIVIMEDLAB stock can currently be purchased for approximately ₹10.55.
3. How can I contact Vivimed Labs Limited?
Vivimed Labs Limited's mailing address is North End Road No.2 Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 6608 6608.
4. What is Vivimed Labs Limited's official website?
The official website of Vivimed Labs Limited is https://www.vivimedlabs.com.